methods for measuring cell-mediated immune response activity in an individual, and for allowing a user to determine the state of an individual's cell-mediated immune responsiveness, and use of at least two sets of peptides

摘要

This disclosure relates generally to the field of immunological-based diagnostic assays including an assay to measure cell-mediated immunoresponsiveness. The present disclosure teaches diagnosis of a subject's exposure to an antigen based on cell-mediated immunoresponsiveness with enhanced sensitivity. The assay contemplated herein is capable of integration into standard pathology architecture to provide a diagnostic reporting system and to facilitate point of care clinical management.